Erratum: Clostridium scindens Is Present in the Gut Microbiota during Clostridium difficile Infection: a Metagenomic and Culturomic Analysis (J Clin Microbiol (2018) 56:5 (e01663-17) DOI: 10.1128/JCM.01663-17);Clostridium scindens is present in the gut microbiota during clostridium difficile infection: a metagenomic and culturomic analysis

Journal of Clinical Microbiology

Volumn 56, Issue 5, 2018, Pages

  Amrane, Sophie ^a   Bachar, Dipankar ^a   Lagier, Jean Christophe ^a   Raoult, Didier ^a  

^a Institut Hospitalo Universitaire   (France)

Author keywords

Clostridium difficile

Indexed keywords

ADOLESCENT; ADULT; AGED; BACTERIUM CULTURE; CHILD; CLINICAL ARTICLE; CLOSTRIDIUM; CLOSTRIDIUM DIFFICILE INFECTION; CLOSTRIDIUM SCINDENS; CONTROLLED STUDY; FECES ANALYSIS; FEMALE; HUMAN; INFANT; INTESTINE FLORA; LETTER; MALE; METAGENOMICS; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SCHOOL CHILD; VERY ELDERLY; CLASSIFICATION; CLOSTRIDIUM INFECTION; DIARRHEA; DNA SEQUENCE; FECES; GENETICS; GROWTH, DEVELOPMENT AND AGING; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTERIOLOGICAL TECHNIQUES; CHILD; CLOSTRIDIUM; CLOSTRIDIUM INFECTIONS; DIARRHEA; FECES; FEMALE; GASTROINTESTINAL MICROBIOME; HUMANS; INFANT; MALE; METAGENOMICS; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA;

EID: 85046288807     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/jcm.01076-22     Document Type: Erratum

References (9)

1. Bokkenheuser VD, Morris GN, Ritchie AE, Holdeman LV, Winter J. 1984. Biosynthesis of androgen from cortisol by a species of Clostridium recovered from human fecal flora. J Infect Dis 149:489–494. https://doi.org/10.1093/infdis/149.4.489.
2. Buffie CG, Bucci V, Stein RR, McKenney PT, Ling L, Gobourne A, No D, Liu H, Kinnebrew M, Viale A, Littmann E, van den Brink MR, Jenq RR, Taur Y, Sander C, Cross JR, Toussaint NC, Xavier JB, Pamer EG. 2015. Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile. Nature 517:205–208. https://doi.org/10.1038/nature13828.
3. Pamer EG, Buffie C, McKenney P. 19 May 2015. Methods and compositions for reducing Clostridium difficile infection. US patent US15312610. https://www.google.fr/patents/US20170087196?dqMethodsandcompositionsforreducingClostridiumdifficiledetection&hlfr&sa X&ved0ahUKEwjC0JHJkK7VAhVLaVAKHb6RC7UQ6AEIJzAA. Accessed 29 July 2017.
4. The American Microbiome Institute. 11 November 2014. A new probiotic candidate to treat C. diff. The American Microbiome Institute Blog. http://www.microbiomeinstitute.org/blog/2014/11/10/a-new-probiotic-candidate-to-treat-c-diff. Accessed 20 July 2017.
5. Kamboj M, Brite J, McMillen T, Robilotti E, Herrera A, Sepkowitz K, Babady NE. 8 December 2017. Potential of real-time PCR threshold cycle (CT) to predict presence of free toxin and clinically relevant C. difficile infection (CDI) in patients with cancer. J Infect https://doi.org/10.1016/j.jinf.2017.12.001.
6. Lagier J-C, Khelaifia S, Alou MT, Ndongo S, Dione N, Hugon P, Caputo A, Cadoret F, Traore SI, Seck EH, Dubourg G, Durand G, Mourembou G, Guilhot E, Togo A, Bellali S, Bachar D, Cassir N, Bittar F, Delerce J, Mailhe M, Ricaboni D, Bilen M, Dangui Nieko NP, Dia Badiane NM, Valles C, Mouelhi D, Diop K, Million M, Musso D, Abrahão J, Azhar EI, Bibi F, Yasir M, Diallo A, Sokhna C, Djossou F, Vitton V, Robert C, Rolain JM, La Scola B, Fournier PE, Levasseur A, Raoult D. 2016. Culture of previously uncultured members of the human gut microbiota by culturomics. Nat Microbiol 1:16203. https://doi.org/10.1038/nmicrobiol.2016.203. Accessed 1 December 2016.
7. Browne HP, Forster SC, Anonye BO, Kumar N, Neville BA, Stares MD, Goulding D, Lawley TD. 2016. Culturing of “unculturable” human microbiota reveals novel taxa and extensive sporulation. Nature 533:543–546. https://doi.org/10.1038/nature17645.
8. Petrof EO, Gloor GB, Vanner SJ, Weese SJ, Carter D, Daigneault MC, Brown EM, Schroeter K, Allen-Vercoe E. 2013. Stool substitute transplant therapy for the eradication of Clostridium difficile infection:’RePOOPulating’ the gut. Microbiome 1:3. https://doi.org/10.1186/2049-2618-1-3. Accessed 28 November 2016.
9. Tvede M, Tinggaard M, Helms M. 2015. Rectal bacteriotherapy for recurrent Clostridium difficile-associated diarrhoea: results from a case series of 55 patients in Denmark 2000 –2012. Clin Microbiol Infect 21:48 –53. https://doi.org/10.1016/j.cmi.2014.07.003.